Bhagwan Devi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 29-12-2024
- Paid Up Capital ₹ 2.00 M
as on 29-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 38.41%
(FY 2022)
- Profit 97.94%
(FY 2022)
- Ebitda -14.29%
(FY 2022)
- Net Worth -0.32%
(FY 2022)
- Total Assets 2.58%
(FY 2022)
About Bhagwan Devi Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Chander Mohan, Sunita Kalara, Monika, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100HR2016PTC057975
- Company No.
057975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Sonipat, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bhagwan Devi Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Mohan  | Director | 10-Feb-2016 | Current |
| Sunita Kalara | Director | 27-Jan-2016 | Current |
| Monika | Director | 24-Jan-2017 | Current |
| Manoj Kalra | Director | 27-Jan-2016 | Current |
Financial Performance of Bhagwan Devi Pharmaceuticals.
Bhagwan Devi Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.41% increase. The company also saw a substantial improvement in profitability, with a 97.94% increase in profit. The company's net worth dipped by a decrease of 0.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhagwan Devi Pharmaceuticals?
In 2022, Bhagwan Devi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chemistaa India Private LimitedActive 13 years 5 daysChander Mohan and Manoj Kalra are mutual person
- Research Medicine Private LimitedActive 22 years 3 months
Chander Mohan and Manoj Kalra are mutual person
- Rescare Pharmaceuticals Private LimitedActive 8 years 1 month
Chander Mohan and Manoj Kalra are mutual person
- Oribelle Cosmetics Private LimitedActive 7 years 8 months
Sunita Kalara and Manoj Kalra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bhagwan Devi Pharmaceuticals?
Unlock and access historical data on people associated with Bhagwan Devi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhagwan Devi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhagwan Devi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
